Neutrophil-activating therapy for the treatment of cancer - Linde, Ian L.; Prestwood, Tyler R.; Qiu, Jingtao; Pilarowski, Genay; Linde, Miles H.; Zhang, Xiangyue; Shen, Lei; Reticker-Flynn, Nathan E.; Chiu, David Kung-Chun; Sheu, Lauren Y.; Van Deursen, Simon; Tolentino, Lorna L.; et al. (Cancer cell, 2023)
Keywords: Animals; Antineoplastic Agents; C5a; cancer immunotherapy; CD40; complement; Humans; leukotriene B4; Leukotriene B4 - metabolism; Leukotriene B4 - pharmacology; Mice; Neoplasms - drug therapy; Neoplasms - metabolism; neutrophil; Neutrophils; reactive oxygen species; tumor immunology; tumor necrosis factor; Tumor Necrosis Factor-alpha - metabolism; xanthine oxidase; CD40; tumor immunology; tumor necrosis factor; cancer immunotherapy; reactive oxygen species; complement; neutrophil; xanthine oxidase; C5a; leukotriene B4